Agios Pharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc. | Key People and Executives

John M. Maraganore

Chairman

David T. Scadden

Independent Director

Ian T. Clark

Independent Director

Andrew J. Hirsch

CFO & Head-Corporate Development

Clive Patience

Senior Vice President-Technical Operations

Carman Alenson

Chief Accounting Officer, VP-Treasury & Tax

Kendra Adams

Senior Director-Investor & Public Relations

Holly Manning

Head-Media

Melissa McLaughlin

Chief People Officer

Min Wang

Secretary, General Counsel & Senior VP

John M. Maraganore

Chairman

David T. Scadden

Independent Director

Ian T. Clark

Independent Director

View Profile

Address	88 Sidney Street Cambridge Massachusetts 02139 United States
Employees	-
Website	http://www.agios.com
Updated	07/08/2019
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. Its product candidates include IDHIFA, ivosidenib, AG-881, AG-348, and AG-270.